author-photo

Renee C. Prins

Oregon Health & Science University

8

Papers

103

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway

2013 Leukemia
Show All
- Source
- Cite
- Save
Citations (41)
Chance favors the prepared mind

2012 Journal of Hospital Medicine
Show All
- Source
- Cite
- Save
Citations (0)
5.50 CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Exhibits CLL Antitumor Activity

2011 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
CX-4945, An Orally Bioavailable Selective Inhibitor of Casein Kinase 2 (CK2), Exhibits Anti-Tumor Activity in Hematologic Malignancies,

2011 Blood
Show All
- Source
- Cite
- Save
Citations (0)